Circulating tumor cells (CTC) and endothelial cells (CEC) changes in HER2 negative metastatic breast cancer (MBC) patients treated with first line weekly paclitaxel and bevacizumab: Preliminary results of a prospective cohort from the French Breast Cancer

Affiliation auteurs!!!! Error affiliation !!!!
TitreCirculating tumor cells (CTC) and endothelial cells (CEC) changes in HER2 negative metastatic breast cancer (MBC) patients treated with first line weekly paclitaxel and bevacizumab: Preliminary results of a prospective cohort from the French Breast Cancer
Type de publicationJournal Article
Year of Publication2015
AuteursPierga J-Y, Vaucher I, Gutierrez M, Tredan O, Guiu S, Romieu G, Goncalves A, Debled M, Levy C, Ferrero J-M, Jouannaud C, Luporsi E, Mouret-Reynier M-A, Dalenc F, Asselain B, Lemonnier J, Bidard F-C
JournalCANCER RESEARCH
Volume75
Date PublishedMAY 1
Type of ArticleMeeting Abstract
ISSN0008-5472